Label: CLEARPROOF SPOT SOLUTION FOR ACNE-PRONE SKIN- salicylic acid cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated June 24, 2020

If you are a consumer or patient please visit this version.

View All Sections
  • PURPOSE

    This spot solution cream is formulated to target current blemishes.

  • Directions:

    Apply directly to affected areas as needed.

    Apply product sparingly to one or two small, affected areas during the first 3 days.

    If no discomfort occurs, follow the directions stated above.

  • Warnings:

    Not to be used for children under 3 years of age.

    Avoid direct contact with eyes.

    If product gets into eyes, rinse thoroughly with water.

  • INGREDIENTS:

    AQUA, ETHYLHEXYL PALMITATE, STEARYL ALCOHOL, GLYCERIN, SALICYLIC ACID, TRIETHANOLAMINE,
    CYCLOPENTASILOXANE, POLYSORBATE 60, PROPYLENE GLYCOL, GLYCERYL STEARATE,
    DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, BUTYL AVOCADATE, ETHYLENE/ACRYLIC ACID COPOLYMER, RETINYL PALMITATE, STEARETH-20, PEG-100 STEARATE, POLYACRYLATE-13, SUCROSE DISTEARATE, CETEARYL ALCOHOL, DIMETHICONE CROSSPOLYMER, SUCROSE STEARATE, POLYISOBUTENE, ARCTIUM LAPPA
    ROOT EXTRACT, CITRIC ACID, DISODIUM EDTA, TITANIUM DIOXIDE/CI 77891, METHYLDIHYDROJASMONATE, C12-14
    PARETH-12, EPILOBIUM ANGUSTIFOLIUM FLOWER/ LEAF/STEM EXTRACT, POLYSORBATE 20, CYCLOHEXASILOXANE, ETHYLENE BRASSYLATE, ETHYL LINALOOL, PHENOXYETHANOL, BUTYLENE GLYCOL, ISOBUTYL METHYL
    TETRAHYDROPYRANOL, METHYLENEDIOXYPHENYL METHYLPROPANAL, METHYLPARABEN, CYSTOSEIRA
    AMENTACEA/CAESPITOSA/BRANCHYCARPA EXTRACT, CHLORPHENESIN, GAMMA-UNDECALACTONE, BENZOIC
    ACID, CYCLAMEN ALDEHYDE, SODIUM METABISULFITE, PROPYL GALLATE, CI 19140, CI 17200, CI 42090

  • Principal Display Panel - 29 g carton

    clearproof

    spot solution for acne-prone skin

    29 g

    image of EU export carton

  • INGREDIENTS AND APPEARANCE
    CLEARPROOF SPOT SOLUTION FOR ACNE-PRONE SKIN 
    salicylic acid cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51531-5439
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
    STEARETH-20 (UNII: L0Q8IK9E08)  
    .GAMMA.-UNDECALACTONE (UNII: QB1T0AG2YL)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SUCROSE STEARATE (UNII: 274KW0O50M)  
    BUTYL AVOCADATE (UNII: Q86RQ0D402)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    DIMETHICONE CROSSPOLYMER (450000 MPA.S AT 12% IN CYCLOPENTASILOXANE) (UNII: UF7620L1W6)  
    ARCTIUM LAPPA ROOT (UNII: 597E9BI3Z3)  
    ETHYLENE BRASSYLATE (UNII: 9A87HC7ROD)  
    ETHYLHEXYL PALMITATE (UNII: 2865993309)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    METHYL DIHYDROJASMONATE (SYNTHETIC) (UNII: 3GW44CIE3Y)  
    EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP (UNII: 08H094218D)  
    CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
    ETHYL LINALOOL (UNII: SF2JS9GF5T)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    3-(3,4-METHYLENEDIOXYPHENYL)-2-METHYLPROPANAL (UNII: L65EG8H6PA)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    BENZOIC ACID (UNII: 8SKN0B0MIM)  
    CYCLAMEN ALDEHYDE (UNII: 4U37UX0E1E)  
    D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
    WATER (UNII: 059QF0KO0R)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    SUCROSE DISTEARATE (UNII: 33X4X4B90S)  
    POLYISOBUTYLENE (2300 MW) (UNII: DSQ2V1DD1K)  
    ACRYLIC ACID/ETHYLENE COPOLYMER (600 MPA.S) (UNII: 1PEZ3NLY6I)  
    C12-14 PARETH-12 (UNII: M0LJS773XW)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    2-ISOBUTYL-4-METHYLTETRAHYDROPYRAN-4-OL (UNII: VK5ZHH2T3F)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PROPYL GALLATE (UNII: 8D4SNN7V92)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51531-5439-11 in 1 CARTON11/30/2017
    129 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Export only11/30/2017
    Labeler - Mary Kay Inc. (049994452)
    Establishment
    NameAddressID/FEIBusiness Operations
    Mary Kay Inc.103978839manufacture(51531-5439)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!